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License 4.0 (CC BY-NC).Sutureless repair of corneal injuries using naturally
derived bioadhesive hydrogels
Ehsan Shirzaei Sani1*, Ahmad Kheirkhah2*, Devyesh Rana3, Zhongmou Sun2, William Foulsham2,
Amir Sheikhi4,5,6, Ali Khademhosseini4,5,6,7, Reza Dana2†, Nasim Annabi1,4,6†
Corneal injuries are common causes of visual impairment worldwide. Accordingly, there is an unmet need for
transparent biomaterials that have high adhesion, cohesion, and regenerative properties. Herein, we engineer a
highly biocompatible and transparent bioadhesive for corneal reconstruction using a visible light cross-linkable,
naturally derived polymer, GelCORE (gel for corneal regeneration). The physical properties of GelCORE could be
finely tuned by changing prepolymer concentration and photocrosslinking time. GelCORE revealed higher
tissue adhesion compared to commercial adhesives. Furthermore, in situ photopolymerization of GelCORE fa-
cilitated easy delivery to the cornea, allowing for bioadhesive curing precisely according to the required geom-
etry of the defect. In vivo experiments, using a rabbit stromal defect model, showed that bioadhesive could
effectively seal corneal defects and induce stromal regeneration and re-epithelialization. Overall, GelCORE
has many advantages including low cost and ease of production and use. This makes GelCORE a promising
bioadhesive for corneal repair.INTRODUCTION
More than 1.5million new cases of corneal blindness are reported every
year (1), of which only less than 5% are treated by corneal transplanta-
tions due to donor tissue shortage and the high expense of transplanta-
tion surgery (2). Corneal injuries and infections are common causes of
corneal scarring and stromal thinning,which can lead to tissue and vision
loss (3). In severe or progressive cases of corneal stromal inflammation,
the stromal matrix may break down substantially to a point where the
structure integrity of the eye is endangered. Current standards of care
for treatment of corneal stromal defects include use of cyanoacrylate glue,
tissue grafting, or corneal transplantation. However, these methods gen-
erally have significant drawbacks. For example, cyanoacrylate glue is
associated with low biocompatibility, poor transparency, rough surface,
difficult handling, and poor integration with corneal tissues (4, 5).
Grafting requires donor tissues, advanced surgical skills, and specialized
equipment. Tissue grafting can also be associated with transplant
rejection and suture-related complications such as cheesewiring through
surrounding necrotic tissue, neovascularization, and microbial entrap-
ment (2, 6). Furthermore, using allogeneic tissue for grafting carries a
high risk of immune reactions, specifically in those with acute injuries
or infections (7). Considering the magnitude of this problem, coupled
with the shortage of donor corneasworldwide, cost-effective and cell-free
biomaterial implants are highly desirable clinically (1).
Adhesive biomaterials have risen as a promising approach for the
treatment of corneal stromal loss, particularly in emergency situations.
In general, biomaterials used for engineering corneal substitutes mustuse physical, structural, and physiobiological characteristics similar to
the native cornea. An ideal biomaterial for corneal repair and regenera-
tion must possess (i) biocompatibility and biodegradability, (ii) me-
chanical stability and appropriate stiffness, (iii) high transparency, (iv)
high adhesion to the native tissue, (v) capability of cell support and
endogenous tissue regeneration, and (vi) clinical compliance for ease
of application and use (8).
Biomaterials used as tissue adhesives for corneal sealing and repair
can be categorized into two classes: (i) synthetic adhesives [e.g., cya-
noacrylates and polyethylene glycol (PEG)–based adhesives] and (ii)
naturally derived adhesives (e.g., fibrin, polysaccharide, collagen-
based adhesives, etc.) (9). Natural biopolymers tend to have excellent bio-
compatibility, but they often have low mechanical stability and
adhesion. Synthetic biopolymers also enable customization of desired
properties; however, they may not lead to tissue regeneration and
biointegration (8). Currently, no available adhesive has been designed
for long-term integration with the cornea even though significant re-
search has been devoted to developing adhesives that can close corneal
incisions (as opposed to “filling in” defects). For example, ReSure
(Ocular Therapeutix Inc., MA, USA), a PEG-based adhesive, is the only
U.S. Food and Drug Administration (FDA)–approved ocular sealant in
the United States, which is designed to seal corneal incisions in cataract
surgery (5). However, ReSure lacks the ability to fill stromal defects. It
also has poor adhesion, especially in wet condition, and falls off quickly
(9). OcuSeal (Beaver-Visitec International, MA, USA) is another PEG-
based adhesive used in Europe for sealing corneal incisions, but it
cannot be used for filling stromal defects, because of uncontrollable
and rapid polymerization, which prevents sufficient time for thorough
application (10). Li et al. also formulated a dual-thiol and acrylate
gelatin-based hydrogel for ocular tissue regeneration; however, the
use of ultraviolet (UV)–light cross-linking can cause corneal or retinal
photochemical cytotoxicity or DNA damage (11, 12). Other natural ad-
hesives, including collagen vitrigel (13, 14), fibrin (15), gelatin (GelFilm
and GelFoam) (16), alginate (17), and chitosan (18) have also been de-
veloped for ocular regeneration applications. However, there is no
existing hydrogel adhesive that combines both regenerative and ad-
hesive properties and can properly mimic natural healing of corneal
tissue (5). In addition, many of these biomaterials lack high adhesion1 of 14
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(e.g., coloration and curvature), transparency, and proper stiffness
required to fully integrate with the native cornea (9).
To address the unmet need of a biocompatible adhesive hydrogel for
corneal tissue repair, we have engineered a gelatin-based adhesive bio-
material, GelCORE (gel for corneal regeneration), which can be used for
quick and long-term repair of corneal stromal defects. The proposed
bioadhesive hydrogel is made of a chemically modified form of gelatin
and photoinitiators, which can be photocrosslinked after short-time
exposure to visible light (450 to 550 nm). Upon completion of photo-
crosslinking, a solid and transparent hydrogel that firmly adheres to
the corneal tissue is formed. Themechanical properties of the engineered
hydrogel adhesives were optimized to mimic the stiffness of the native
cornea. In addition, the adhesive formulations were modified to obtain
high adhesion strengths to the cornea, while retaining appropriate
biodegradability and high cytocompatibility in vitro. The adhesion
characteristics of the bioadhesives were then tested on the basis of
standard adhesion tests provided by American Society for Testing
and Materials (ASTM) and compared to commercially available ad-
hesives. Ex vivo tests on explanted rabbit eyes were also performed to
evaluate the retention and burst pressures. Last, in vivo tests were con-
ducted using a rabbit stromal cornea defect model to test the bio-
compatibility and retention of the biomaterial, as well as the corneal
regeneration after bioadhesive application.RESULTS
Synthesis and physical characterization of the
adhesive hydrogels
We synthesized a transparent, flexible, and adhesive photocrosslinkable
hydrogel for the treatment of corneal stromal defects. The engineered
hydrogel mimicked the mechanical properties of the native cornea and
comprised a chemically modified form of hydrolyzed collagen, which
provides enzymatic degradation sites and physiological cell adhesion
motifs (19). UV cross-linkable gelatin-based sealants for sealing and re-
pair of lung tissues (19) and sclera (11) have been reported.However, the
use of UV light can induce DNA damage (20) and can cause corneal or
retinal photochemical toxicity (21, 22), as well as carcinogenesis (23).
Specifically, UV-A (the longer wavelength) can cause retinal damage
deeper within the eye (i.e., macular degeneration), and UV-B (the
shorter wavelength) can cause damage to the surface of the eye (i.e.,
photokeratitis or corneal sunburn) (24). This limits the use of UV-
mediated cross-linking techniques for corneal repair. To overcome
the biosafety concerns associated with UV-initiated cross-linking, we
investigated a visible light cross-linking system to formGelCORE ad-
hesives, where light intensity is well under the maximum permissible
exposure limit (25). In our work, the adhesive hydrogels could be
cross-linked through a free radical polymerization process, in the pres-
ence of a type 2 initiator Eosin Y, as well as triethanolamine (TEA) and
N-vinylcaprolactam (VC) as co-initiator and co-monomer, respectively
(Fig. 1A).
The visible light cross-linking scheme has been proven to improve
cell viability, compared to UV cross-linked systems (26–28). Briefly,
the visible light photons excite the photoinitiator molecules (Eosin Y)
to a triplet state, which allow them to accept hydrogen atoms from co-
initiator molecules (TEA). The deprotonated radicals then undergo
vinyl-bond cross-linkingwith co-monomer (VC) via chain polymeriza-
tion. This will result in accelerated gelation of the polymeric scaffolds
(29). This visible light photocrosslinking chemistry is an FDA-approvedShirzaei Sani et al., Sci. Adv. 2019;5 : eaav1281 20 March 2019system (30) and has been used previously as a safe photocrosslinking
system for biomedical applications (29, 31, 32). A schematic of the poly-
mer network photocrosslinking process with representative images of the
cross-linked adhesive on a corneal defect are shown in Fig. 1B. The hy-
drogel prepolymer solution could be easily and rapidly applied to a cor-
neal stromal defect and photopolymerized, allowing the defects with
varied shapes and sizes to be quickly sealed and thus promoting re-
generation of new stromal tissue (Fig. 1, B to D). Accordingly, after
creation of corneal stromal defect (Fig. 1Bi), the GelCOREprepolymer
is applied to fill the defect site (Fig. 1Bii). Next, in the early stages of the
healing process, the corneal epithelial layer begins to regenerate (Fig.
1Biii), and the full stromal regeneration occurs at the late repair pro-
cess (Fig. 1Biv).
To determine the cross-linking density of the hydrogel network,
500-MHz proton nuclear magnetic resonance (1H NMR) analysis was
performed on GelCORE prepolymers and GelCORE hydrogels photo-
crosslinked at 1-, 2-, and 4-min visible light exposure times using tech-
niques previously defined (fig. S1) (32). Results showed thatmethacryloyl
(methacrylate/methacrylamide, --C=CH2) functional groups in the
GelCORE backbone with characteristic peak 1 at d = 5.3 parts per mil-
lion (ppm) and peak 2 at d = 5.7 ppm were incorporated in the forma-
tion of the cross-linked three-dimensional (3D) bioadhesive network.
Accordingly, the degree of cross-linking could be calculated by mea-
suring the alteration in integrated areas of themethacryloyl peaks before
and after the photocrosslinking process (32). On the basis of our results,
it was found that the degree of cross-linking increased from 63.4 ± 2.7%
to 88.9 ± 7.9% when visible light exposure time was increased from 1 to
4 min for 20% GelCORE concentration (fig. S2). Comparatively, we
previously reported the formation of a UV–cross-linkable gelatin-based
hydrogel as a lung sealant, which demonstrated >95% cross-linking
density after 3-min UV exposure time (19).
Physical properties (i.e., mechanical properties, in vitro swelling
ratio, and degradability) of GelCORE adhesive hydrogels were charac-
terized. Mechanical properties of the bioadhesives were determined
through compression and tensile tests (Fig. 1, E to G). Our results re-
vealed that by varying the concentration of GelCORE and the photo-
crosslinking time, the critical mechanical properties of the hydrogel
could be finely controlled to derive formulations with tensile and
compressive moduli that are comparable to the native cornea (Fig.
1, E to G). For instance, the compressive modulus of adhesive hydro-
gels engineered with 5% (w/v) GelCORE increased from 1.2 ± 0.5 kPa
to 4.5 ± 1.2 kPa as the light exposure time increased from 1 to 4 min,
respectively (Fig. 1F). In addition, increasing the prepolymer concen-
tration remarkably enhanced the mechanical properties of the bioad-
hesives. For instance, the compressive modulus of hydrogels formed
by using 4-min light exposure time was increased 66.4-fold from 4.5 ±
1.2 kPa for 5% polymer concentration to 299.9 ± 30.0 kPa for 20%
polymer concentration (Fig. 1F). This highlights the wide range of
controllable moduli, which can be obtained just by changing either
polymer concentration or photocrosslinking time. Comparatively,
the compressive moduli of the adhesive hydrogels were well encom-
passing of the range of moduli of native cornea (115.3 ± 13.6 kPa),
which is crucial for long-term tissue/biomaterial integration and
remodeling (Fig. 1F). Rizwan et al. (33) formed UV cross-linked
gelatin-based hybrid patches for corneal tissue regeneration with simi-
lar compressive moduli (ranged from 28.8 to 233.3 kPa) when the total
polymer concentration changed from 10 to 30% (w/v). However, the
application of this prefabricated graft required advanced surgical skills
and equipment (33).2 of 14
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Fig. 1. Synthesis, application, and in vitro characterization of GelCORE adhesive hydrogels. (A) Schematic of the chemical reaction for GelCORE formation and
photocrosslinking of the prepolymer solution with Eosin Y (photoinitiator), TEA (co-initiator), and VC (co-monomer). (B) Schematic diagram for the application of
GelCORE for rapid and long-term repair of corneal injuries, which include (i) formation of stromal defect, (ii) application of the bioadhesive, (iii) regeneration of the
epithelial layer, and (iv) stromal regeneration. (C) The prepolymer solution is injected into the corneal defect and exposed to visible light, forming (D) an adhesive
GelCORE hydrogel. (E) Representative compressive stress-strain curves, (F) compressive moduli, and (G) elastic moduli of GelCORE adhesive hydrogels fabricated using
5%, 10%, and 20% (w/v) total polymer concentrations with varying photocrosslinking time points. (H) Water content of GelCORE adhesives produced by using 20% (w/v)
polymer concentration and varying visible light exposure times at 37°C in DPBS over time. (I) In vitro degradation of 20% (w/v) GelCORE adhesive (4-min photocrosslinking
time), in different concentrations of collagenase type II (Col II) solution in DPBS and 37°C over time. All hydrogels were polymerized by using 0.1 mM Eosin Y, 1.5% (w/v) TEA,
and 1% (w/v) VC in distilled water. Data are reported as means ± SD (*P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001; n ≥ 3).Shirzaei Sani et al., Sci. Adv. 2019;5 : eaav1281 20 March 2019 3 of 14
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elastic moduli (Fig. 1G) and ultimate tensile strength (UTS) (fig. S3)
by varying the GelCORE concentration and visible light exposure time.
For example, the Young’smoduli of adhesive hydrogels engineeredwith
5% (w/v) GelCORE enhanced from 6.7 ± 0.8 kPa to 16.0 ± 2.1 kPa by
increasing the photocrosslinking time from at 1 to 4 min (Fig. 1G). In
addition, theYoung’smoduli of the adhesivehydrogels photocrosslinked
at 4 min increased 14-fold from 16.0 ± 2.1 kPa to 224.4 ± 32.3 kPa by
increasing the total polymer concentration from 5 to 20% (w/v) (Fig.
1G). Furthermore, the UTS of engineered bioadhesives was consistently
increased from 38.0 ± 6.1 kPa to 45.3 ± 4.1 kPa for 20% (w/v) GelCORE,
when the photocrosslinking time increased from 1 to 4 min (fig. S3).
Similar to compressive tests, these results demonstrated that the elastic
moduli of the GelCORE bioadhesives were in the range of native corneal
tissue (121.8 ± 11.6 kPa) (Fig. 1G). This enhancement in stiffness of the
hydrogels at higher polymer concentrations or light exposure time can
be due to the higher cross-linking densitywithin the hydrogel network as
confirmed by 1H NMR analysis.
In addition to mechanical properties, water content and enzymatic
degradation of the engineered adhesive hydrogels were also charac-
terized. The degree of hydration (water content) of the GelCORE ad-
hesives was measured in Dulbecco’s phosphate-buffered saline (DPBS)
(37°C, 48 hours). After 48 hours of incubation, no significant differences
were observed in the water content of the GelCORE samples synthe-
sized at 1-, 2-, and 4-min photocrosslinking time. In addition, the
degree of hydration did not alter by time, when incubated for 48 hours
in DPBS (37°C). Furthermore, the water content of the samples was in
the range of 85.9 to 89.5% (Fig. 1H), which was found to be comparable
to the degree of hydration of the native human cornea (85 to 86%) (34).
The enzymatic degradations of photocrosslinked GelCORE hydro-
gels were measured by incubating them in different concentrations
(0, 2.5, 5, and 40 mg/ml) of collagenase type II solution in DPBS for
up to 10 days (Fig. 1I). Results showed that the enzyme concentra-
tion could directly affect in vitro degradation rate of the hydrogels.
For example, the adhesives showed 100% degradation after 4 days of
incubation at the highest enzyme concentration (40 mg/ml). However,
13.8 ± 1.6%, 28.9 ± 11.1%, and 46.9 ± 2.4% degradations were obtained
after 4 days, when the samples were incubated in different enzyme con-
centrations (0, 2.5, and 5 mg/ml, respectively) (Fig. 1I). Moreover, the
degradation rate of 20% (w/v) GelCORE bioadhesives increased from
15.1 ± 4.3% to 90.7 ± 7.0%by increasing enzyme concentration from0 to
5 mg/ml after 10 days of incubation (Fig. 1I). The ability to control and
tune the degradation rates of the hydrogels is remarkably advanta-
geous for the implementation of GelCORE as an adhesive for ocular
applications. This can promote simultaneous bioadhesive enzymatic
degradation and tissue integration, which can result in the new corneal
stromal tissue ingrowth.
Overall, the physical characterization of GelCORE adhesive hydro-
gels demonstrated that themechanical properties and in vitro enzymatic
degradation can be tuned by changing total polymer concentration and
photocrosslinking time. This significant degree of tunability suggests that
the GelCORE bioadhesive could be readily adjusted for various surgical
and tissue engineering applications, especially regeneration of corneal
stroma defects.
In vitro adhesion properties of GelCORE bioadhesives
In general, high adhesion of hydrogels to the adjacent tissue can avoid
biomaterial detachment from target tissues in vivo and eventually pro-
mote potential biointegration. An ideal tissue and biomaterial integra-Shirzaei Sani et al., Sci. Adv. 2019;5 : eaav1281 20 March 2019tion improves biocompatibility and enhances tissue regeneration under
physiological conditions (35). Herein, we examined critical properties
for effective bioadhesion, including shear strength, adhesion strength,
and burst pressure, according to ASTM standards for biological adhe-
sives. In these standards, the in vitro adhesion strength and sealing
properties of GelCORE adhesive hydrogels, produced at various pre-
polymer concentrations and visible light exposure times, were com-
pared to commercial surgical sealants, Evicel and CoSEAL (Fig. 2).
To investigate burst pressures of the engineered adhesives, air was
continuously pumped into a custom-designed burst pressure apparatus.
The adhesive polymers were applied to seal a standardized defect in a
porcine intestine sheet as a biological substrate, based on a modified
ASTM standard test, F2392-04 (Fig. 2A). The sealed tissue es then
placed in the burst pressure apparatus.Our results showed that the burst
pressures of GelCORE adhesives significantly increased from 10.8 ±
1.6 kPa to 63.1 ± 8.5 kPa as the GelCORE concentration was increased
from 5% (w/v) to 20% (w/v) at 4-min photocrosslinking time (Fig. 2B).
Comparatively, Gratieri et al. (18) reported burst pressures of approx-
imately 12 kPa for a chitosan-based adhesive for ocular regeneration.
This value is significantly lower than GelCORE-based adhesives
presented here. Furthermore, cyanoacrylate glues for corneal repair
showed burst pressure of approximately 68 kPa, which is comparable
to our engineered adhesives (36). However, cyanoacrylate glues are gen-
erally toxic and show low biocompatibility and poor transparency (4, 5).
Moreover, a UV–cross-linkable gelatin-based adhesive used for ocular
application achieved maximum a burst pressure of around 12 kPa as
well (36, 37), which is below the value obtained for GelCORE adhesives
[~58 to 63 kPa for 20% (w/v) polymer concentration at 1- to 4-min light
exposure time, respectively]. Furthermore, burst pressures of GelCORE
adhesive hydrogels in all tested concentrations [5, 10, and 20% (w/v)]
were significantly higher than both clinically available sealants, with a
range of 11.1 ± 0.6 kPa to 63.1 ± 8.5 kPa as compared to 1.5±0.7 kPa for
Evicel and 1.6 ± 0.2 kPa forCoSEAL (Fig. 2B). GelCORE adhesive hydro-
gels additionally showed higher burst pressures than values of 0.3 ±
0.3 kPa for CoSEAL, as reported by Campbell et al. (38). Further-
more, our GelCORE adhesive achieved higher burst pressures than
DuraSeal (0.8 kPa) and fibrin sealant (0.2 kPa) (38). In addition, it was
reported that majority modes of failure for these commercial products
were related to the cohesive properties of the materials (38). This indi-
cates that these bioadhesives were inherently weak. It should be noted
that burst pressure values for 20% GelCORE sealant were not signifi-
cantly improved when increasing the photocrosslinking time from
1 to 4 min (Fig. 2B).
Next, the shear strengths of the engineered bioadhesives were inves-
tigated using a modified test based on ASTM standard F2255-05 (Fig.
2C). Similar to the burst pressure results, a wide range of shear stresses
were obtained, indicating fine controllability and repeatability of shearing
properties. The highest shear strength was observed for a 20% (w/v)
GelCORE bioadhesive (375.2 ± 28.0 kPa) at 4-min photocrosslinking.
This value was significantly higher than the lap shear strength of Evicel
(207.7 ± 67.3 kPa) and CoSEAL (69.7 ± 20.6 kPa) (Fig. 2D). Moreover,
increasing the photocrosslinking time from 1 to 4 min improved the
shear strength of GelCORE adhesives for all tested concentrations.
For example, the shear strength of 10% (w/v) GelCORE adhesive in-
creased from 15.6 ± 2.9 kPa to 246.5 ± 12.6 kPa by increasing photo-
crosslinking time from 1 to 4 min as shown in Fig. 2D.
Last, the adhesion strengths of the engineered adhesives were in-
vestigated using amodified wound closure test based on ASTM stan-
dard F2458-05 (Fig. 2E). Similarly, a higher adhesive strength was4 of 14
SC I ENCE ADVANCES | R E S EARCH ART I C L Eobserved at higher concentration of GelCORE. For example, 20%
GelCORE hydrogels, cross-linked via 4-min visible light exposure,
reached an adhesive strength of 90.4 ± 10.2 kPa. This value was re-
markably higher than that of CoSEAL (19.4 ± 17.3 kPa) and Evicel
(26.3 ± 4.7 kPa) (Fig. 2F). This was also higher than adhesiveShirzaei Sani et al., Sci. Adv. 2019;5 : eaav1281 20 March 2019strengths obtained by other commercially available bioadhesives or
sealants such as Quixil (24.6 kPa), Beriplast (24.2 kPa), Tachosil
(59.6 kPa), and Tisseel (77.5 kPa) (39). In addition, it was found that
the adhesive strengths of the engineered GelCORE adhesives were also
affected by the light exposure time. For example, adhesion strengthsA
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Fig. 2. In vitro adhesion properties of GelCORE hydrogels using porcine skin and intestine as biological substrates. (A) Schematic of themodified test for burst pressure
measurements (ASTM F2392-04) and (B) average burst pressure of GelCORE adhesives (n ≥ 3) produced with varying polymer concentrations and photocrosslinking times,
compared to two commercial adhesives including Evicel and CoSEAL. (C) Schematic of the modified test for lap shear strength measurements (ASTM F2255-05) and (D) average
shear strengths of GelCORE adhesives (n ≥ 3) produced with varying polymer concentrations and photocrosslinking times, Evicel, and CoSEAL. (E) Schematic of themodified test
for wound closure test (ASTM F2458-05) and (F) average adhesive strengths of GelCORE adhesives (n ≥ 3) produced with varying polymer concentrations and photocrosslinking
times, compared to Evicel and CoSEAL. Data are means ± SD (*P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001). (Photo credit: Ehsan Shirzaei Sani, UCLA)5 of 14
SC I ENCE ADVANCES | R E S EARCH ART I C L Eincreased from 57.5 ± 3.5 kPa to 90.4 ± 10.2 kPa as exposure time was
increased from 1 to 4 min for a 20% GelCORE hydrogel (Fig. 2F).
Overall, the measurement of mechanical and adhesive properties of
GelCORE adhesives showed excellent cohesion and adhesion for 20%
GelCORE concentration. The wound closure strength, shear resistance,
and burst pressure for a 20% (w/v) GelCORE bioadhesive were sig-
nificantly higher than clinically available PEG-based (Evicel) and
fibrin-based (CoSEAL) controls.
Ex vivo retention and burst pressure of the
GelCORE bioadhesive
Dimensional stability and retention time for GelCORE bio-
adhesives were investigated on corneal tissues ex vivo by using slit
lamp biomicroscopy and anterior segment optical coherence tomog-
raphy (AS-OCT) (Fig. 3). Upon creation of a corneal defect in ex-
planted New Zealand rabbit eyes (3 mm in diameter and >50%
deep), the adhesive precursor solutions [10 and 20%(w/v)] were ap-
plied to the defect site and exposed to visible light for 1, 2, and 4 min,
forming a transparent hydrogel with a smooth surface and complete
corneal curvature (Fig. 3A). The GelCORE hydrogel could strongly
adhere to the explanted tissue (movie S1). After application of the
bioadhesives, eyes sealed with hydrogels were stored in DPBS at 4°C,
and changes in bioadhesive structure and retention were assessed over
time using serial evaluations with slit lamp biomicroscopy andAS-OCT
(Fig. 3, A to C). Upon observation, all examined hydrogels showed firm
adhesion to the corneal stroma. In addition, results revealed that reten-
tion times for 10 and 20% (w/v) GelCORE at 4-min photocrosslinking
times were 15 and 17 days, respectively. This was 2.1 and 2.5 times high-
er than the retention times for 20%GelCORE formed at 1-min exposure
time, respectively (Fig. 3B). This observation can be correlated to higher
adhesion strengths of 10 and 20% (w/v) GelCORE adhesives at 4 min
exposure time based on the wound closure test (Fig. 2F). It was also
noted that for the duration of a 20-day assessment period, the bioad-
hesives remained uncompromised (thickness and spread were fully re-
tained), and the adhesives were completely attached to the cornea in all
tested eyes (Fig. 3C). Slit lampbiomicroscopy also corroborated that dur-
ing this time period, the bioadhesive remained transparent with a
smooth surface without any microscopic signs of changes in shape
or contour. AS-OCT also confirmed no change in thickness or shape
of the bioadhesive after 28 days (Fig. 3C).
An ex vivo burst pressure test was also performed to measure the
burst pressures of bioadhesives on rabbit eyes (Fig. 3D). Accordingly,
a 2-mm full-thickness incision was created in the cornea, followed
by sealing with either GelCORE bioadhesives or ReSure (as control).
For this test, GelCORE adhesive precursors and ReSure were applied
to the corneal incision sites in explanted rabbit eyes and cross-linked
in situ. The sealed eye was then connected to a burst pressure apparatus
containing a syringe pump and a pressure sensor. Air was injected con-
tinuously, increasing pressure until bursting of the sealant (Fig. 3D).
Burst pressures of explanted eyes sealed with 20% GelCORE adhesives
engineered at varying visible light exposure times (1, 2, and 4min) were
measured using a digital wireless sensor (Fig. 3E). Burst pressures of
the GelCORE adhesives formed at 4-min photocrosslinking were
found to be 30.1 ± 4.3 kPa. This was approximately 10 times higher
than that of normal eye pressure and significantly higher than burst
pressure of the commercial control, ReSure (15.4 ± 6.3 kPa) (Fig. 3E).
Last, by increasing the photocrosslinking time from 1 to 4 min, burst
pressures of 20% (w/v) bioadhesives increased from 10.4 ± 1.5 to 30.1
± 4.3 kPa (Fig. 3E).Shirzaei Sani et al., Sci. Adv. 2019;5 : eaav1281 20 March 2019Inclusively, the adhesive hydrogels engineered by using 20%GelCORE
and photocrosslinked by using 4-min exposure time showed the highest
ex vivo burst pressure resistance and retention time. Therefore, this hy-
drogel formulation was selected for in vitro cell studies and in vivo as-
sessment of bioadhesive retention and cornea tissue regeneration.
In vitro assessment of cytocompatibility and integration
of GelCORE bioadhesive
The optimal bioadhesive for corneal repair should be biocompatible
with no cytotoxicity. It should also permit cells of the injured tissue
to migrate into the bioadhesive for long-term integration and repair.
Therefore, we aimed to evaluate the in vitro cytocompatibility and cell
migration for the engineered adhesives using 2D cell seeding and
scratch tests (Fig. 4).
To accomplish this, cytocompatibility of engineered bioadhesives
was assessed in vitro. The viability, adhesion, proliferation, and meta-
bolic activity of human cornea fibroblast cells (keratocytes) seeded on
GelCORE adhesiveswere evaluated by using a commercial kit for LIVE/
DEADassay andPrestoBlue tests. In addition, the resultswere compared
to viability and methanolic activity of the cells seeded on tissue culture
well-plates and ReSure sealant as controls. The results showed that the
cells seeded on both tissue culture well-plate control and bioadhesives
(20% GelCORE) exhibited high viability (>90%) 1, 4, and 7 days after
seeding (Fig. 4, A to B and D). In contrast, the cell viability for ReSure
sealant was significantly lower than GelCORE adhesive (<65%) during
the same time period (Fig. 4, C and D). The quantification of cell meta-
bolic activity also confirmed this observation, where the metabolic ac-
tivity of keratocytes seeded on ReSure was 1.2- and 2.8-fold lower than
the cells seeded onGeCORE adhesive on days 1 and 7 after seeding (Fig.
4E). In addition, metabolic activity of keratocytes seeded on GelCORE
adhesive increased consistently from 4008 ± 1795 relative fluorescence
units (RFUs) at day 1 to 31,139 ± 697 RFUs at day 7 after seeding, re-
spectively (Fig. 4E). Furthermore, actin/4′,6-diamidino-2-phenylindole
(DAPI) staining exhibited an increase in cell spreading on theGelCORE
bioadhesive over time (fig. S4).
The in vitro scratch assay also revealed that keratocytes seeded on
the surface of both well plate and adhesive hydrogels could migrate to
the scratched area (400- to 500-mm distance) in less than 24 hours (Fig.
4, F andG). In addition, to quantify themigration to thewound area, we
compared cell density in the scratched area to the surrounding cell den-
sity. The results showed that the relative cell density for GelCORE ad-
hesive hydrogels was significantly higher than that of the control (tissue
culture plate) 1, 2, and 3 days after creating the scratch (Fig. 4H). For
example, the relative cell density for GelCORE hydrogel was 94.4 ±
3.4%, which was 36% higher than the control (well plate). This indicates
that cell migration and proliferation on the surface of GelCORE adhe-
sives were higher than that of the control (Fig. 4H).
Many researchers investigated cytotoxicity and biocompatibility of
synthetic bioadhesives and sealants in vitro and in vivo, and the cyto-
toxic nature of some of the synthetic bioadhesives has been widely re-
ported (9, 40–42). For example, Chen et al. (40) reported high levels of
corneal cytotoxicity for methoxypropyl cyanoacrylate and N-butyl
cyanoacrylate, while fibrin glue showedminimal cytotoxicity in their
studies. However, cyanoacrylate-based adhesives showed a higher capa-
bility to seal corneal incisions compared with fibrin glue. In another
study, Fürst and Banerjee (41) showed high in vitro and in vivo toxicity
of BioGlue, which is a sealant based on bovine serum albumin and
glutaraldehyde cross-linker. Their results revealed that cross-linked
BioGlue released significant amounts of glutaraldehyde that can cause6 of 14
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Fig. 3. Ex vivo application and adhesion properties of GelCORE adhesives. (A) Representative slit lamp photographs from rabbit eyes sealed by GelCORE bioad-
hesive, and (B) retention times of GelCORE bioadhesives, formed at various cross-linking times and prepolymer concentrations, on cornea tissues. (C) Representative
optical coherence tomography images after ex vivo application of GelCORE adhesives to rabbit corneas at days 1, 14, and 28 after application. (D) Schematic of ex vivo
burst pressure set up, including a syringe pump, a pressure sensor, and a recording system. (E) Average burst pressure of GelCORE adhesives formed by varying
photocrosslinking time, compared to a commercially available ocular sealant, ReSure (control). Data are represented as means ± SD (**P < 0.01, ***P < 0.001, and
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SC I ENCE ADVANCES | R E S EARCH ART I C L Ecytotoxic and histotoxic effects on lung, arteries, and liver (41). In ad-
dition, it has been reported that BioGluemay cause serious nerve injury,
mineralization, and coagulation necrosis (9), which dramatically reduces
its possible application in ophthalmic surgeries (9). In contrast, our results
indicated that GelCORE adhesive hydrogels prepared with visible light–
initiated system are nontoxic to keratocytes. In addition, the adhesive hy-
drogel can support proliferation, adhesion and spreading, and metabolic
activity of corneal cells in vitro. Therefore, GelCORE adhesive hydrogels
maybe able to effectively enhance the healing process of corneal defects.
In vivo assessment of GelCORE bioadhesives in a rabbit
stromal defect model
In our previous studies, we confirmed in vivo biocompatibility of UV
and visible light cross-linked gelatin-based bioadhesives. This was doneShirzaei Sani et al., Sci. Adv. 2019;5 : eaav1281 20 March 2019via subcutaneous implantation of disk-shaped hydrogels in rats (32)
and in situ polymerization of gelatin-based sealants on incisions created
on porcine lungs (19). In addition, we also confirmed in vivo bio-
compatibility of photocrosslinked gelatin hydrogel through direct
injection into the myocardium and in situ polymerization (29). Our
results showed that the hydrogels could degrade after 2 weeks without
inducing significant inflammatory response while promoting tissue
formation.
Herein, for the first time, we assessed the use of our engineered
bioadhesives specifically designed for corneal sealing in a corneal injury
model in New Zealand white rabbits. This was done by creating 50%-
deep corneal defects in rabbit cornea (Fig. 5, A andB, andmovies S2 and
S3) to evaluate the biocompatibility and biointegration of the engineered
GelCORE hydrogels for repair and sealing of corneal defects. AfterT im e po s t-s e e d in g (d a y )
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Fig. 4. In vitro cytocompatibility of GelCORE bioadhesives. Representative LIVE/DEAD images from corneal fibroblast cells seeded on (A) tissue culture well-plate,
(B) GelCORE adhesives, and (C) ReSure sealant on days 1, 4, and 7 after seeding (scale bar, 100 mm). (D) Quantification of cell viability on GelCORE bioadhesives
compared to tissue culture well plate and ReSure after 1, 4, and 7 days of culture. (E) Quantification of metabolic activity of corneal fibroblast cells seeded on control
(tissue culture well plate), GelCORE hydrogels, and ReSure after 1, 4, and 7 days. Representative LIVE/DEAD images of corneal fibroblast cells grown on (F) tissue culture
well plate and (G) GelCORE hydrogels based on a 2D scratch assay at 0, 1, and 3 days after scratching. (H) Quantification of relative cell densities migrated to the
scratched area on GelCORE adhesives and control samples, at days 0, 1, 2, and 3. GelCORE hydrogels formed at 20% (w/v) final polymer concentration were used for 2D
cell culture studies (photocrosslinking time, 4 min). Data are represented as means ± SD (**P < 0.01, ***P < 0.001, and ****P < 0.0001; n ≥ 3).8 of 14
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Shirzaei Sani et al., Sci. Adv. 2019;5 : eaav1281 20 March 2019creating a half-thickness corneal stromal defect, a 20% (w/v) GelCORE
bioadhesive precursorwas applied into the defect site (Fig. 5C), followed
by in situ polymerization via visible light for 4 min (Fig. 5D and movie
S4) (n ≥ 4). Immediately after photocrosslinking, there was a firm ad-
hesion of the bioadhesive to the corneal defect (movies S5 and S6).
In addition, 1 day after surgery, the implanted bioadhesives were
transparent, revealing a smooth surface. In addition, the surrounding
cornea was transparent and noninflamed (Fig. 5E). AS-OCT also con-
firmed that the hydrogel was able to completely fill the defect and ad-
here to the stromal bed (Fig. 5, F and G). One week after surgery, the
bioadhesive could be still observed on the defect site in the cornea and
remained transparent (Fig. 5G).
In addition, as shown in Fig. 6A, the adhesive hydrogels remained
transparent 1, 7, and 14 days after application. We also investigated
whether there is migration of the epithelium over the adhesive hydrogel
in the rabbit cornea. Cobalt blue slit lamp photographs with fluorescein
staining showed progressive reduction of the size of corneal epithelial
defect (Fig. 6B), implicating the migration of the epithelium over the
bioadhesive (fluorescein stains epithelial defects in green). By day 14
after application, the corneal epithelial defect over the bioadhesive
was completely healed (Fig. 6B).
Moreover, histological evaluation of cryo-sectioned tissues revealed
the strong adhesion of GelCORE bioadhesive to the stromal tissue after
application (Fig. 7B). In addition, the results showed growth of non-
inflammatory stromal tissue without any dominant deposition of a
fibrous collagenous capsule after 14 days of application (Fig. 7D), which
was similar to native cornea (Fig. 7A). Furthermore, histological as-
sessment showed that the thickness of the corneal stromal layer for
GelCORE-treated samples (582.2 ± 95.8 mm) was in the same range as
that of the native rabbit cornea (554.9 ± 39.1 mm) (Fig. 7E). The stromal
layer in untreated samples could not regenerate properly (Fig. 7C) and
exhibited a thickness of 177.9 ± 39.3 mm (Fig. 7E). The thickness of the
corneal epithelial layer was also evaluated histologically. Results re-
vealed no statistically significant differences in the thickness of corneal
epithelial layers inGelCORE treated, untreated, and native corneas (Fig.
7F). However, untreated samples showed a comparatively larger SD for
thickness of the corneal epithelial layer as compared to native tissueIn situ application of GelCORECreating an incision on rabbit cornea
Photocrosslinking
Defect
A B C
D E
GelCORE
After application
GelCORE
G
Defect
Before applicationF
GelCORE
Fig. 5. In vivo applicationofGelCOREbioadhesives into corneal defects in rabbits.
(A and B) Representative images for creating a 50% depth corneal stromal defect on
rabbit eye. (C) In situ application of GelCORE prepolymer solution into corneal defect.
(D) Photocrosslinking and (E) formation of a transparent GelCORE adhesive hydrogel
on corneal stromal defect. AS-OCT images (F) before and (G) after treatment with
GelCORE. Seven days after application, the bioadhesive still had a smooth surface.
GelCORE hydrogels were prepared by using 20% (w/v) total polymer concentration
and 4-min light exposure time. [Photo credit: (A to E) Amir Sheikhi, UCLA]A
B
Fig. 6. Corneal re-epithelialization after in vivo application of the bioadhesive to corneal defects in rabbit cornea. (A) Representative slit lamp photographs and
(B) cobalt blue with fluorescein staining after in vivo application of GelCORE adhesive to rabbit cornea at different time points. Progressive reduction in the size of
corneal epithelial defect (green area in the central cornea) implicates epithelial migration over GelCORE. (Photo credit: Ahmad Kheirkhah, MEE, Harvard Medical School)9 of 14
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Fig. 7. Histological analysis after application of GelCORE bioadhesive in a rabbit corneal stromal defect model. Representative hematoxylin and eosin histo-
pathology images from (A) native rabbit corneas (without defect) and (B) rabbit cornea after application of GelCORE in a 50% depth stromal defect. Histological images
for (C) untreated stromal defect (without bioadhesive) and (D) the defect treated with bioadhesive at day 14 after surgery (scale bars, 50 mm and 1 mm). (E) Thickness of
stromal layer for the native cornea, GelCORE-treated, and untreated eyes at day 14 after surgery obtained from histological images. (F) Thickness of epithelial layer for
native cornea and GelCORE-treated and untreated eyes at day 14 after surgery obtained from histological images. (G) Representative fluorescent immunohistochemical
images (DAPI and CD45 marker) (i) from the area without defect and (ii) from corneal stromal defect treated with GelCORE bioadhesive at day 14 after surgery. GelCORE
hydrogels were prepared at 20% (w/v) total polymer concentration and 4-min light exposure time. Data are represented as means ± SD (****P < 0.0001; n ≥ 3).Shirzaei Sani et al., Sci. Adv. 2019;5 : eaav1281 20 March 2019 10 of 14
SC I ENCE ADVANCES | R E S EARCH ART I C L Ewhich indicates heterogenous re-epithelialization of untreated samples
(Fig. 7F).
The thickness of the corneal epithelial layer was also evaluated
histologically. Results revealed no statistically significant differences in
the thickness of corneal epithelial layers inGelCORE-treated, untreated,
and native corneas (Fig. 7F). However, untreated samples showed a
larger SD for thickness of the corneal epithelial layer as compared to
native tissue, which indicates heterogeneous re-epithelialization of un-
treated samples (Fig. 7F). The immunostaining results (DAPI staining)
also indicated homogenous re-epithelialization in GelCORE treated
group (Fig. 7Gii) after 14 days, similar to native cornea (Fig. 7Gi).More-
over, leukocyte infiltration was detected by expression of CD45 maker
in the GelCORE-treated corneas, showing normal inflammatory re-
sponses during the regeneration process (Fig. 7Gii) (43). In addition,
an autologous tissue regeneration was observed for the defects treated
with GelCORE bioadhesive after 14 days of application (Fig. 7Gii). The
cell nuclei within the new tissue showed the similarities between re-
generated tissue and native tissue (Fig. 7G).DISCUSSION
Conventional standards of care for corneal stromal defects have sig-
nificant drawbacks including poor biomechanical, optical, or adhesive
properties, as well as lack of biocompatibility and regenerative capability.
To overcome these limitations, in this study, we developed a bio-
compatible and adhesive hydrogel for corneal tissue sealing and repair.
In our system, gelatin is chemically functionalized with methacryloyl
groups to form a visible light activated GelCORE bioadhesive. Our
results show that physical properties and adhesion strength of GelCORE
bioadhesives can be tuned by changing GelCORE concentration and
light exposure time. In vitro cell studies show that engineered hydrogels
are cytocompatible with corneal cells and promote cell integration after
application. Furthermore, in vivo experiments show that GelCORE can
effectively seal corneal defects and promote re-epithelialization. Other
researchers have also aimed to develop tissue-engineered transplants
for the treatment of corneal epithelial defects and stromal ulcers to re-
duce the dependence on donor corneas. However, the majority of these
methods are based on prefabricated membranes (13) or patches (33),
which typically require surgical equipment and skills. In addition,most
of these prefabricated transplants are “passive” cell-based approaches,
which are potentially associated with high cell loss during implantation
and immunogenicity (44, 45). In contrast, our approach uses a bio-
compatible adhesive for sutureless and cell-free sealing and treatment
of corneal stromal defects without requiring advanced surgical pro-
cedures. In addition, different tissue adhesives, including fibrin-based
(i.e., fibrin glue, Tisseel) and PEG-based (i.e., ReSure) bioadhesives,
have also been tested for ophthalmic applications. The major drawback
of these adhesives is that they lack high adhesion to wet corneal tissue,
nor do they have long retention (9). Fibrin-based adhesives may also
have the risk of transmitted diseases from pooled and single blood do-
nors (46). PEG-based bioadhesives also suffer from similar limitations,
including uncontrolled cross-linking, which are impractical in a clinical
setting, and they lack the required mechanical properties that would ef-
ficiently promote regeneration (9).
Last, an important feature of the GelCORE biomaterial is its ability
to permit normal regenerative responses while it fills in corneal stromal
defects of different size and geometry. This can lead to corneal tissue
regeneration, encourages faster recovery of patients, reduces the need
for future visual rehabilitativemeasures, and, in some cases, circumventShirzaei Sani et al., Sci. Adv. 2019;5 : eaav1281 20 March 2019the need for corneal transplantation. Overall, our results showed that
the bioengineeredGelCORE adhesive hasmany advantages highlighted
throughout this study, making it a promising substance for use in cor-
neal repair.MATERIALS AND METHODS
Fabrication of GelCORE bioadhesive hydrogels
GelCORE prepolymer was synthesized on the basis of previously pub-
lished protocol (19). Briefly, 10 g of porcine gelatin (Sigma-Aldrich) was
dissolved in 100ml ofDPBS and heated at 60°C for 1 hour.Next, 8ml of
methacrylic anhydride (Sigma-Aldrich) was added dropwise to gelatin
solution under continuous stirring at 50°C for 3 hours. The solutionwas
then diluted with DPBS and dialyzed against deionized water at 50°C
for 5 days. The resulting solution was then filtered and lyophilized for
3 days. The photoinitiator solution was prepared by dissolving TEA
[1.875% (w/v)], VC [1.25% (w/v)], and Eosin Y disodium salt (0.5mM)
in distilled water at 37°C. GelCORE precursor solutions were prepared
by dissolving varying concentrations of GelCORE [5, 10, and 20% (w/v)]
in the photoinitiator solution. The bioadhesive prepolymer solution was
then vortexed at 37°C, and immediately, 70 ml of the precursor solution
was pipetted into polydimethylsiloxane cylindrical molds (diameter,
6mm; height, 2.5mm) for compression testing, or rectangular molds
(14 mm by 5 mm by 1 mm) for tensile testing. The solution was then
photocrosslinked with visible light (450 to 550 nm) for 1, 2, and 4 min,
using an LS1000 Focal Seal Xenon Light Source (100 mW/cm2,
Genzyme).
1H NMR analysis of GelCORE bioadhesives
1H NMR analysis was performed to measure degree of cross-linking of
GelCORE bioadhesive hydrogels as described elsewhere (32). Briefly,
GelCORE adhesives were prepared in cylindrical molds and lyophilized
as described earlier. Then, both GelCORE adhesives and prepolymer
were partially dissolved in DMSO-d6. 1H NMR spectra were obtained
from GelCORE bioadhesive hydrogels at different cross-linking times
and prepolymer solutions using a Varian Inova-500 NMR spectrome-
ter. The peaks for the hydrogen atoms in methacryloyl (methacrylate
and methacrylamide) groups were identified at d = 5.3 and 5.7 ppm.
Next, the area under these peaks was integrated for all the samples.
At different light exposure times, the changes in the integrated area
with respect to prepolymer solution were reported as degrees of cross-
linking of bioadhesive hydrogels. This area was calculated using the
following equation
Decay of methacryloyl groups ð%Þ ¼ Ab  Aa
Ab
 100 ð1Þ
where Ab and Aa show the integrated areas of methacryloyl groups
before and after photocrosslinking, respectively.
Mechanical characterization of the GelCORE bioadhesives
Hydrogels were prepared as described above. The precise dimensions of
the fabricated bioadhesives were obtained using a digital caliper.
Mechanical testing (tensile and compression) was conducted using an
Instron 5542 mechanical tester. For tensile tests, rectangular hydrogels
were fixed between double-sided tapes fastened to the Instron’s tension
grips. Samples were stretched at a rate of 1 mm/min until rupture. The
load (in newtons) and tensile strain (in millimeters) values were re-
corded using the accompanying Bluehill 3 software. Elastic moduli of11 of 14
SC I ENCE ADVANCES | R E S EARCH ART I C L Ethe fabricated bioadhesives were obtained bymeasuring the slope of the
stress-strain curves (0.1 to 0.3 mm/mm strain). The UTS was obtained
from the point of failure. For compressive experiments, cylindrical
bioadhesives were placed in the Instron’s compressive plates in a DPBS
bath. The compression test was conducted at a rate of 1mm/min up to a
max strain of 70%. Similarly, the values for compressive strain (inmil-
limeters) and load (in newtons) were recorded using the Bluehill 3
software. The compressive moduli were calculated from the slope of
the linear region (0.1 to 0.2mm/mmstrain) on the stress (in kilopascals)
versus strain (millimeter per millimeter) curves (n ≥ 3).
In vitro adhesion tests
Burst pressure test
Sealing capability of engineered bioadhesives and commercially
available sealants, CoSEAL (Baxter, Deerfield, IL, USA) and Evicel
(Ethicon, Somerville, NJ, USA), weremeasured according to amodified
ASTM standard, F2392-04, for burst pressure, as described previously
(47). Briefly, porcine intestine was fixed in the middle of two stainless
steel annuli, using a custom-made burst pressure apparatus inwhich the
upper annuli contained a 10-mm-diameter hole. Using an 18-gauge sy-
ringe needle, a 2-mm-diameter hole was created in the intestine tissue.
Next, 30 ml of prepolymer solution was pipetted on the defect area and
quickly cross-linked by visible light. Next, the air was applied into the
system, and themaximum burst pressure was recorded by using a wire-
less sensor (Pasco) (n ≥ 3).
Lap shear test
Shear strength of GelCORE bioadhesive, as well as Evicel, and CoSEAL
were measured using a modified lap shear test based on ASTM stan-
dard, F2255-05 according to previously published protocol (47). As a
replacement for the substrate, twopieces of glass slides (10mmby50mm)
were coated with a 20% (w/v) gelatin solution at 37°C and were dried at
room temperature. Next, 10 ml of precursor solution was pipetted and
photocrosslinked between two pieces of glass slides. The shear strengths
of the samples were then tested using an Instron mechanical tester, as
described previously. Tensile stress was then applied (1 mm/min), and
the shear strengths of the bioadhesives were measured at the detach-
ment point (n ≥3).
Wound closure test
Wound closure capability of GelCORE bioadhesives, as well as Evicel
and CoSEAL were measured using a modified ASTM standard test,
F2458-05 (48). Porcine skin, purchased from a local butcher shop,
was cut into small pieces (1 cm by 2 cm), and the excess fat was re-
moved. The porcine skins were kept hydrated in DPBS before testing
and then fixed onto two pieces of glass slides (20 mm by 60 mm) by
superglue. The space between glass slides was adjusted to 10 mm by
using the tissue. An incision was made to simulate a wound using a
straight edge razor. One hundred milliliters of polymer solution was
administered onto thewound site and cross-linked via exposure to visible
light. The ultimate adhesive strength of bioadhesives wasmeasured at the
detachment point using an Instronmechanical tester. Tensile loadingwas
conducted at strain rate of 1mm/min using the Instronmechanical tester
as described above (n ≥ 5).
In vitro measurement of water content of the
adhesive hydrogels
Adhesive hydrogels were prepared as described before. The wet weights
of the fresh samples were then measured. Samples were subsequently
immersed in DPBS for 48 hours. The weights of each hydrogel were
recorded at varying time points. The water content was then calculatedShirzaei Sani et al., Sci. Adv. 2019;5 : eaav1281 20 March 2019using Eq. 2, whereWS is swollen weight of the bioadhesive and WD is
the initial weight before swelling (n ≥ 4)
Water content ¼WS WD
WD
 100 ð2Þ
In vitro enzymatic degradation of the adhesive hydrogels
The in vitro degradation of bioadhesives was examined as described
previously (47). Disc-shaped GelCORE samples (d = 6 mm; h =
3 mm) were formed as described before. Next, the initial weights of
the samples weremeasured, and the sampleswere incubated in different
concentrations (0, 2.5, 5, and 40 mg/ml) of collagenase type II (Thermo
Fisher Scientific) inDPBS for 1, 2, 3, 4, 7, and 10 days. At each time point,
the finalweights of the samplesweremeasured. The degradation percent-
age of each sample was calculated based on the weight loss over time.
In vitro cell studies
Cell lines
Corneal fibroblast cells [American Type Culture Collection (ATCC)]
were cultured at 37°C and 5% CO2 in Dulbecco’s modified Eagle’s me-
dium (DMEM): Nutrient Mixture F-12 (DMEM/F12) (Sigma-Aldrich)
containing 10% (v/v) fetal bovine serum, 1% (v/v) antibiotic/antimycotics
(Sigma-Aldrich), and 1% (v/v) L-glutamine (Sigma-Aldrich). Cells were
maintained in flasks (tissue culture treated) and passaged when reached
to 70% confluency.
2D cell seeding on GelCORE bioadhesives
Hydrogel prepolymer solution was prepared as previously described.
Seven microliters of precursor solution was then pipetted between a
3-(trimethoxysilyl) propyl methacrylate (TMSPMA; Sigma-Aldrich)–
coated glass slide and a petri dish separated with a 300-mm spacer.
The prepolymer solutions were then photocrosslinked for 4min via vis-
ible light. Next, 40 ml of corneal fibroblast cell solution (2 × 106 cells/ml)
was seeded on each sample. After 45-min incubation, 360 ml of cell
culture media was added to each sample, and they were maintained
at 37°C and 5% CO2 for 5 days. In addition, cells at the same density
were also seeded inside 24-well tissue culture plates. As the commercial
control, the tissue culture well plates were coated with ReSure sealant,
and the same cell density (40ml, 2 × 106 cells/ml) was seeded in eachwell.
2D cell scratch test
Hydrogel prepolymer solution was prepared as previously described.
Forty microliters of precursor solution was then pipetted between
a TMSPMA-coated glass slide and a petri dish separated with a 300-mm
spacer. Hydrogels were then photocrosslinked for 4min via exposure to
visible light. Corneal fibroblast cells (2 × 106 cells/ml) were then seeded
on the hydrogels andmaintained at 37°C and 5%CO2. After 2 days, the
cell layer on the surface of the hydrogels was scratched using a 1-ml
pipette tips. The cells were stained at day 0, 1, 2 and 3 after creating
scratch. Polystyrene 24-well plates were used as control.
Determination of cell proliferation
PrestoBlue assay (Thermo Fisher Scientific) was used for determi-
nation of cell proliferation using the instruction provided by the
manufacturer. Briefly, cells seeded on the adhesives were stained
with a solution containing 10% (v/v) PrestoBlue dye in media.
Then, the samples were incubated for 1 hour at 37°C in the PrestoBlue/
medium solution before measuring fluorescence. Fluorescence inten-
sity of the stained solution was then measured at 535- to 560-nm
excitation and 590- to 615-nm emission wavelength on days 1, 4,
and 7 of culture.12 of 14
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The viability of corneal fibroblast cells was obtained using a calcein
acetoxymethyl (calcein AM) and ethidium homodimer-1 LIVE/DEAD
assay from Invitrogen based on the instruction provided by themanufac-
turer. Briefly, calceinAM(0.5ml/ml) and ethidiumhomodimer-1 (2ml/ml)
were diluted in DPBS to form the staining solution. Cell medium was
removed fromwells containing scaffolds, and 100 ml of staining solution
was added. Cell-seeded scaffolds were then incubated for 15min at 37°C,
in the dark. Live (green stain) anddead (red stain) cellswere imagedusing
an inverted fluorescentmicroscope fromZEISS (AxioObserver Z1). Last,
the cell viability was quantified by dividing the number of the live cells by
total number of cells, using ImageJ software.
Determination of cell adhesion and spreading
Cell spreading in 2D cultures was visualized by F-actin microfilaments
and cell nuclei fluorescent staining, as described previously (47). Briefly,
cell seeded hydrogels were washed with DPBS (three times) and then
fixed with 4% (v/v) paraformaldehyde solution (Sigma-Aldrich) for
20 min. After fixation, the samples were washed again three times with
DPBS. Fixed samples were permeabilized in 0.1% (w/v) Triton X-100
(Sigma-Aldrich) in DPBS for 20 min. The samples were then triple-
washed with DPBS, and cell actin filament was stained via Alexa Fluor
488–labeled phalloidin [1.25% (v/v) in 0.1% bovine serum albumin, Invi-
trogen] for 45 min, followed by another triple wash with DPBS. Last,
cell nuclei were stained with DAPI (1 ml/ml; Sigma-Aldrich) in DPBS
for 5 min, followed by a final wash with DPBS. Immediate microscopy
image acquisition was performed using an Axio Observer Z1 inverted
microscope.
Rabbit corneal surgeries
Surgical procedures
For in vivo experiments, 8- to 12-week-old male New Zealand white
rabbits were purchased from the Jackson Laboratories (Bar Harbor,
ME). Survival surgeries in rabbits were performed under aseptic
conditions. To induce corneal injury, a lamellar (partial thickness)
keratectomy was performed in rabbit eyes. For this, after general anes-
thesia using intramuscular injection of ketamine (30 to 50 mg/kg) and
xylazine (5 to 10mg/kg) and topical anesthesia proparacaine 0.5% oph-
thalmic solution, a 3-mm biopsy punch was used to make a partial
trephination (cut) in the central cornea of the right eye to a depth of
approximately 50%. Then, a surgical knife was used to perform a lamellar
keratectomy at the same depth. The bioadhesives were then applied and
photopolymerized as described before [20% (w/v), 4-min visible light
exposure time]. Following the surgical procedures, the rabbits were kept
warm by placing them on a heating pad until recovery from the an-
esthesia. All the rabbits received buprenorphine (0.01 to 0.5 mg/kg) by
subcutaneous injection every 12 hours for 48 hours. The rabbit eyes
were then evaluated using slit lamp biomicroscopy and AS-OCT at
1 and 2weeks after surgery. These tests were also performed under gen-
eral anesthesia as described before. At the end of the study, the rabbits
were euthanized, and the eyes were explanted for histologic analysis
(after 2 weeks).
Slit lamp biomicroscopy
Slit lamp biomicroscopy was performed under general anesthesia
using a Topcon system. Slit lamp photographs were also taken at
the time of examination. With a ×16 magnification, using slit and
broad beams, transparency of the bioadhesive and the surrounding
cornea was evaluated. To assess the migration of corneal epithelium
over the adhesive, cobalt blue slit lamp photography with fluorescein
staining was performed.Shirzaei Sani et al., Sci. Adv. 2019;5 : eaav1281 20 March 2019Anterior segment optical coherence tomography
AS-OCT was performed under general anesthesia at days 0, 7, and 14
after surgery. AS-OCT is a high-resolution cross-sectional and noncon-
tact imaging system.A spectral-domainAS-OCT (Spectralis, Heidelberg
Engineering, Germany), with an axial resolution of 3.9 to 7 mm,was used
for imaging.
Histological analysis
After explantation of the rabbit corneas, the samples were fixed in
4% (v/v) paraformaldehyde overnight. Next, they were embedded in
optimal cutting temperature compound and quickly frozen in liquid
nitrogen. Using a Leica Biosystems CM3050 S Research Cryostat, the
samples were then sectioned (6 mm) and fixed on positively charged
glass slides. For the staining, a hematoxylin and eosin kit (Sigma-
Aldrich) was used according to the manufacturer’s instructions. For
immunostaining, anti-CD45 antibody (ab10558) (Abcam) and Alexa
Fluor 488–conjugated (Invitrogen) were used as primary and sec-
ondary antibodies according to manufacturer’s protocol. Next, the
slides were mounted with DPX mountant medium (Sigma-Aldrich)
and visualized on an AxioObserver Z1 inverted microscope.
Statistical analysis
For each experiment, at least three samples were tested, and data were
presented as means ± SD (*P < 0.05, **P < 0.01, ***P < 0.001, and
****P < 0.0001). One-way or two-way analysis of variance (ANOVA)
t test was performed followed by Tukey’s test for statistical analysis
(GraphPad Prism 6.0, GraphPad Software).SUPPLEMENTARY MATERIALS
Supplementary material for this article is available at http://advances.sciencemag.org/cgi/
content/full/5/3/eaav1281/DC1
Fig. S1. 1H NMR spectra of GelCORE prepolymer and GelCORE bioadhesives.
Fig. S2. Quantification of degree of cross-linking for GelCORE hydrogels.
Fig. S3. UTS of GelCORE hydrogels.
Fig. S4. Representative actin/DAPI images for corneal fibroblast cells seeded on GelCORE
hydrogels.
Movie S1. Ex vivo adhesion of GelCORE bioadhesives on rabbit eyes.
Movie S2. Creating corneal defect in rabbit cornea using a biopsy punch.
Movie S3. Creating corneal defect in rabbit cornea using a surgical knife.
Movie S4. Photocrosslinking of the GelCORE bioadhesive with visible light.
Movie S5. Firm adhesion of the bioadhesive to the corneal defect.
Movie S6. Firm adhesion of the bioadhesive to the corneal defect.REFERENCES AND NOTES
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